Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

As Long as Google Inc (GOOG) Fires Crazy Moonshots Like Calico, I’m a Happy Investor

Google Inc (NASDAQ:GOOG) just started a health care business. This is awesome news for Google investors, but not for the obvious reasons.

The new company is known as Calico, and will focus on health issues with an extreme long-term view. I mean the type of long-term research into issues like aging and chronic illness that traditional drug researchers just can’t do. They’re under the thumb of shareholders looking for short-term profits, and can’t afford to take huge swings at projects with an uncertain outcome.

But Calico can and will take these long-view risks with Google Inc (NASDAQ:GOOG)’s blessing and fundamental backing. It’s not about making money, but about making the world a better place.

Google Inc (NASDAQ:GOOG)I’m excited to see Tim Cook openly supporting this Google Inc (NASDAQ:GOOG) project, especially since Calico CEO Arthur Levinson had to give up his Google board seat amid the Android-iPhone wars. The cold war between these tech giants may finally be thawing a little. And it’s great to see biotech giant Roche’s leadership supporting the kind of research that its own investors would never let it spend millions on. The company will have the pedigree to get something done. Levinson comes with decades of industry experience, having served as CEO of Genentech for 14 years. He’s still the chairman of Genentech and Apple Inc. (NASDAQ:AAPL), and holds a board seat at larger Swiss company Roche, which owns Genentech these days. Franz Humer, Roche’s CEO, seems excited about working with Levinson’s new company. Apple CEO Tim Cook praised Levinson as “one of the crazy ones” who wants to stretch our lifespans and improve quality of life in the twilight years.

As a Google Inc (NASDAQ:GOOG) investor and a human being, this announcement tickled me pink. I’m obviously interested in living longer and more comfortably, but that humanitarian angle isn’t the main attraction here.

This project underscores Google Inc (NASDAQ:GOOG)’s commitment to making the world a better place in general. “Do no evil” is real, even after all these years. The company’s official mission is to “organize the world’s information and make it universally accessible and useful.” Do it right and the money will follow.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.